Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FHF48
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,387
Award facts
- Contract value 100% obligated
- $72,386.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Cosentyx (secukinumab) 300 mg dose in 2 pen/mL formulation, with a ceiling value of $72,386.59 and a completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award status. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains significant federal contract relationships focused on supplying pharmaceutical products and medical supplies to defense and veteran healthcare systems. The company's substantial IDC with DLA encompasses a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Cosentyx delivery order represents a specific procurement fulfillment under that framework, supporting military medical supply chain requirements for this specialty immunosuppressant medication.
Quick answers
Who was awarded contract SPE2DB25FHF48?
SPE2DB25FHF48 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FHF48 worth?
The government has obligated $72,387 on SPE2DB25FHF48.
Is contract SPE2DB25FHF48 an order under another contract?
Yes. SPE2DB25FHF48 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHF48 competed?
The extent of competition for SPE2DB25FHF48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award